Arvind Trindade, MD, discusses a large database study looking at rising rates of pancreatic and colon cancer in young adults.

A metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) could be used to address this type of cancer that often resists treatments. Scientists at the University of Michigan have ...

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is ...

Arvind Trindade, MD, discusses the background of a study investigating rates of pancreatic and colon cancer among younger patients.

Increase seen across age groups, while incidence of colorectal adenocarcinoma increased most in those aged 15 to 34 years.

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups.

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

KWES morning anchor Victor Lopez let viewers know that he is fighting stage 4 colon cancer. "I was diagnosed with ...

Waist circumference is a stronger predictor of obesity-related cancer risk than BMI in men, but not in women, due to ...

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ's dense tissue to define the ...

(Alliance News) - Hutchmed China Ltd on Tuesday said it has completed patient enrolment for a phase II registration trial of savolitinib, targeting gastric cancer in patients with MET gene ...